Finding new drugs has traditionally been a laborious process requiring extensive laboratory work. A new artificial intelligence startup is now working to streamline this pipeline by leveraging AI to skip traditional lab work entirely. As detailed in a WIRED report published on November 5, 2026, this development highlights the growing role of artificial intelligence in reshaping pharmaceutical research and accelerating the identification of potential new treatments.